| 摘要 |
A method of treating an autoimmune disease, such as, diabetes or psoriasi s, by administering an anti-CD3 antibody, or anti-CD3 antibody fragment. The anti-CD3 antibody, or anti-CD3 antibody fragment, is administered over a co urse of treatment wherein, during the course of treatment, the anti-CD3 anti body, or anti-CD3 antibody fragment is administered in a total amount which does not exceed 300 .mu.g/kg when administered intravenously or, when admini stered other than intravenously, is administered in a total amount that does not exceed a total amount bioequivalent to 300.mu.g/kg of intravenous admin istration thereof.
|
